ConvaTec Group PLC

Common Name
ConvaTec Group
Country
United Kingdom
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
10,000
Ticker
CTEC
Exchange
LONDON STOCK EXCHANGE
Description
ConvaTec Group plc is a global medical products and technologies company, specializing in advanced wound care, ostomy care, continence & critical care, and infusion care. It serves healthcare professi...

ConvaTec Group's Financial Statements Preview

Below are the financial statements of ConvaTec Group, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024
2023
Revenue
2,289.2a
2,142.4a
Cost of sales
-1,005.6a
-941.8a
Gross profit
1,283.6a
1,200.6a
Selling and distribution expenses
-645.2a
-612.5a
General and administrative expenses
-195a
-212.9a
Research and development expenses
-111.7a
-110a
Other operating expenses
-6.8a
-2.5a
Operating profit
324.9a
262.7a
Finance income
4.8a
5.2a
Finance expense
-82.9a
-80.7a
Fair value movement of contingent consideration
-4.6a
-24.6a
Non-operating income, net
3.7a
4.8a
Profit before income taxes
245.9a
167.4a
Income tax expense
-55.4a
-37.1a
Net profit
190.5a
130.3a
Download Data

Verified Sources Behind ConvaTec Group’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore ConvaTec Group’s data sources below and access millions more through our Disclosure Search.

a. ConvaTec Group's Annual Report 2024
a. ConvaTec Group's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?